Brandon, Timothy G.
Xiao, Rui
Peterson, Rosemary G.
Chauvin, Nancy A.
Francavilla, Michael L.
Biko, David M.
Rumsey, Dax G.
Stoll, Matthew L.
Weiss, Pamela F. https://orcid.org/0000-0002-9724-0443
Funding for this research was provided by:
Rheumatology Research Foundation (Innovative Research Award)
Article History
Received: 27 September 2021
Accepted: 9 November 2021
First Online: 2 December 2021
Declarations
:
: This study’s protocol was reviewed and approved by the University of Alabama at Birmingham’s (IRB-160701011) and Children’s Hospital of Philadelphia’s (IRB 16–013015) Committees for the Protection of Human Subjects and the ethics committee at the University of Alberta (REB Pro00081651). Waivers of consent and HIPAA authorization were granted as procedures represented minimal risk to the subjects and did not adversely affect the rights and welfare of the subjects.
: Not applicable.
: Dr. Weiss has served as a consultant for Lilly and Novartis.